Xiong Huang

2 papers in the library · 12 citations · publishing 2016-2025

Papers

Sort Most recent Most cited

Efficacy and safety of esketamine versus propofol in electroconvulsive therapy for treatment-resistant depression: A randomized, double-blind, controlled, non-inferiority trial.

Journal of Affective Disorders 2025 Qing-Bin Zeng, De-Cheng Zou, Xing-Bing Huang et al. 12 citations

Electroconvulsive therapy (ECT) is a commonly used alternative for treatment-resistant depression (TRD). Although esketamine has a rapid pharmacological antidepressant action, it has not been studied as an ECT anesthetic. The objective of this study was to compare the efficacy and safety of esketamine with propofol when both are used as ECT anesthetic agents. Forty patients with TRD were...

DOI: 10.1016/j.jad.2024.09.038 Full text Esketamine Propofol Electroconvulsive therapy ect Shock therapy +7

Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression.

Journal of Affective Disorders September 1, 2016 Xiaomei Zhong, Hongbo He, Chunping Zhang et al.

Treatment-resistant depression (TRD) is a growing clinical challenge. Electroconvulsive therapy (ECT) is an effective tool for TRD treatment. However, there remains a subset of patients who do not respond to this treatment with common anesthetic agent. Ketamine, a noteworthy anesthetic agent, has emerged as an augmentation to enhance the antidepressant efficacy of ECT. Trials of i.v. ketamine...

DOI: 10.1016/j.jad.2016.05.011 Full text